baber/WOPTO huggingface dataset:
Patent EP-3516431-A1 (EP)
Inventor: QIU YONGXING
IPC: B29D11/00
Filed: 2017-09-14
Abstract: The invention is related to a method for producing soft contact lenses comprises a silicone hydrogel lens body and a composite coating thereon. The composite coating comprises: a plasma base coating which is chemically-attached directly onto the surface of the silicone hydrogel contact lens and functions as a fail-proof measure for ensuring the hydrophobic silicone hydrogel lens material to be shielded from any exposure to ocular environments even after at least 30 days of daily uses including daily waring and daily cleaning/disinfecting; and a relatively-durable lubricious hydrogel top coating for ensuring wearing comfort. A method of the invention comprises forming a plasma-reactive hydrophilic polymer hybrid base coating having reactive functional groups on a silicone hydrogel contact lens and heating the silicone hydrogel contact lens with the hybrid base coating in an aqueous solution of a water-soluble and thermally crosslinkable hydrophilic polymeric material to form a stable lubricious hydrogel coating thereon. This method has a minimized adverse impact on the mechanical properties of silicone hydrogel lens body.
Patent EP-3445823-A1 (EP)
Title: Matériau adsorbant métallique et ses utilisations
Inventor: CHALKER JUSTIN MARK
IPC: B01D53/14
Filed: 2017-04-20
Abstract: L'invention concerne un polysulfure polymère. Le polysulfure polymère est formé en faisant réagir une composition d'acides gras comprenant au moins un acide gras insaturé ou un dérivé de celui-ci avec du soufre, selon un rapport pondéral compris entre 9:1 et 1:9, dans des conditions de vulcanisation inverse pour produire un polysulfure polymère dans lequel au moins 50 % des acides gras ou de leurs dérivés présents dans la composition d'acides gras sont insaturés.
Patent EP-3525793-A1 (EP)
Inventor: LOPEZ-LOPEZ CRISTINA
IPC: A61K31/5377
Filed: 2017-10-11
Abstract: The present invention relates to an oxazine derivative BACE-1 inhibitor and pharmaceutical compositions comprising such oxazine derivative for use in the treatment or prevention of cerebral amyloid angiopathy and, in particular, wherein the patient carries one or two copies of the ApoE4 allele.
Patent EP-3532244-A1 (EP)
Inventor: BOWLES KAY
IPC: B24C3/32
Filed: 2017-10-19
Abstract: A system and a method for reduction of dimensional end-taper in abrasive blasted tubes (300) includes a pressurized chamber (301), which maintains higher air pressure inside the chamber than atmospheric pressure, an air-exit port (302) that allows gases to exit from the chamber at a controlled rate, a valve which restricts the passage of gases from the air-exit port, a pressurized membrane through which the tube passes to create a seal (303), a gauge port (304) where the pressure inside the pressurized chamber is monitored with a gauge and a media-exit port (305) for evacuation of abrasive blast media particles after they are expelled from the exit-end of the tube. The system provides a solution to dimensional end-taper as high back pressure at the exit end of the tube reduces the velocity of the gases (220) and the abrasive particles (230) carried in it, thereby reducing the extent of erosion of the inner walls of the tube near its exit end.
Patent EP-3445907-A1 (EP)
Inventor: PRAVEEN KANNAN UDAYAPPAN
IPC: D06F87/00
Filed: 2017-10-31
Abstract: Stain removal accessory (171) intended to cooperate with a stain removal device (1) for treating a stained area, the stain removal accessory (171) is attached to the front head of the stain removal device (1), namely to the water and/or steam venting face of said stain removal device (1), and comprises a container (400) like a pad, a cartridge, a sachet or a capsule provided with a permeable external layer, for containing a stain removing material (300), and a holder (600) for holding said container (400), whereby said stain removal accessory (171) is adapted to release said stain removing material (300) on the stained area when cooperating with the stain removal device (1) by facing the flow of water and/or steam (200) generated by said stain removal device (1).
Patent EP-3545044-A1 (EP)
Inventor: GEBERS JAN
IPC: C09D129/04
Filed: 2017-11-20
Abstract: A coating composition comprising a polymer containing hydroxy groups, such as a water soluble polyvinyl alcohol, and further comprising a tetraalkoxysilane and modified silica nanoparticles having a positively charged surface shows advantageous properties such as low refractive index, good transparency and low haze.
Patent EP-3549269-A1 (EP)
Inventor: LI WEI
IPC: H04B1/7075
Filed: 2017-12-01
Abstract: A method of operating a digital radio receiver comprising: receiving a radio signal; passing said radio signal to a correlator for correlating said radio signal with a predetermined pattern to provide an output signal comprising a plurality of peaks separated in time; determining an amplitude of a first peak in the plurality of peaks; calculating a selection threshold based on said first peak amplitude; determining an amplitude of a second peak in the plurality of peaks; comparing said second peak amplitude to the selection threshold; and identifying the second peak as a correlation peak if the second peak amplitude is greater than the selection threshold.
Patent EP-3552253-A1 (EP)
Inventor: MATSUYAMA TSUYOSHI
IPC: H01L51/44
Filed: 2017-11-27
Abstract: To provide a photoelectric conversion element, including a first substrate, a first transparent electrode disposed on the first substrate, a hole-blocking layer disposed on the first transparent electrode, an electron-transporting layer that is disposed on the hole-blocking layer and includes an electron-transporting semiconductor on a surface of which a photosensitizing compound is adsorbed, a hole-transporting layer that is connected to the electron-transporting layer and includes a hole-transporting material, and a second electrode disposed on the hole-transporting layer, wherein the photoelectric conversion element includes an output extraction terminal part configured to extract electricity out from the photoelectric conversion element, and the output extraction terminal part is formed with a plurality of micropores piercing through the hole-blocking layer.
Patent EP-3476857-A1 (EP)
Inventor: KONNO HIDEO
IPC: C07F15/00
Filed: 2017-06-16
Abstract: A method for producing a cyclometalated iridium complex by allowing an iridium compound and an aromatic bidentate ligand to react each other. In particular, the method is characterized by allowing a ²-diketonate salt represented by General Formula (4) to coexist in a reaction system for reaction. By adding the ²-diketonate salt into the reaction system, stability of a reaction intermediate product between the iridium compound and the aromatic bidentate ligand improves. Therefore, yield of the cyclometalated iridium complex can improve. The cyclometalated iridium complex produced in accordance with the present invention is useful as a phosphorescent material for use in an organic EL element, for example.
Patent EP-3474866-A1 (EP)
Title: Cellules exprimant le récepteur d'hormone parathyroïde 1 et leurs utilisations
Inventor: PASPALIARIS VASILIS
IPC: A61K48/00
Filed: 2017-06-21
Abstract: La présente invention concerne des cellules souches pluripotentes cultivées avec un ou plusieurs peptides et des procédés d'isolement desdites cellules souches. L'invention concerne en outre des procédés de ciblage des cellules souches vers une région ou une zone souhaitée à l'intérieur d'un organisme. L'invention concerne en outre des procédés d'utilisation des cellules souches isolées pour l'amélioration de la fertilité, pour la stimulation de la croissance des cheveux, pour le traitement ou la prévention d'affections cutanées, pour le traitement ou l'amélioration de troubles osseux, pour le traitement de malignités et pour le traitement de troubles neurologiques.
Patent EP-3556166-A1 (EP)
Inventor: HUANG YI
IPC: H04W72/04
Filed: 2017-11-22
Abstract: A method, an apparatus, and a computer program product for wireless communication are provided. The apparatus may receive an uplink control configuration indication in a downlink control portion of a first slot. The first slot may include the downlink control portion, a second portion, and an uplink short burst portion. The second portion may be located between the downlink control portion and the uplink short burst portion. The apparatus may configure a physical uplink control channel (PUCCH), on at least one of the second portion or the uplink short burst portion of the first slot, for transmission of first uplink control information (UCI) based at least in part on the uplink control configuration indication. The first UCI may correspond to second UCI to be transmitted in the first slot or a second slot. The apparatus may transmit the first UCI on the configured UCI.
Patent EP-3485275-A1 (EP)
Title: Réactifs d'hybridation couplés à un antigène
Inventor: SCHWARTZ DAVID A
IPC: G01N33/574
Filed: 2017-07-18
Abstract: La présente invention concerne des réactifs d'hybridation à haute performance destinés à être utilisés dans divers dosages d'hybridation et autres techniques apparentées. Les réactifs d'hybridation comprennent une sonde oligonucléotide et un antigène de pontage, l'antigène de pontage étant reconnu par un anticorps détectable avec une affinité élevée. L'invention concerne également des compositions comprenant des panneaux de réactifs d'hybridation spécifiques pour de multiples acides nucléiques cibles différents et des compositions comprenant des paires de réactifs d'hybridation et leurs anticorps complémentaires détectables. Les paires de réactifs d'hybridation et les anticorps détectables sont utiles dans divers dosages d'hybridation, en particulier dans les dosages fortement multiplexés, où la structure de l'antigène de pontage varie en tandem avec la variation de l'anticorps détectable, de façon qu'une multiplicité de réactifs d'hybridation peuvent détecter simultanément une multiplicité d'acides nucléiques cibles dans un même dosage. Des kits comprenant les réactifs d'hybridation, des procédés de dosage d'hybridation utilisant les réactifs d'hybridation de l'invention, et des procédés de préparation desdits réactifs d'hybridation sont également décrits.
Patent EP-3559670-A1 (EP)
Inventor: PANGRATZ-FÜHRER SUSANNE
IPC: G01N33/68
Filed: 2017-12-22
Abstract: L'invention concerne une méthode permettant de diagnostiquer une lésion cérébrale chez un nouveau-né, comprenant une étape d'analyse du taux de crystalline alpha-B dans un échantillon de tissu ou de fluide corporel provenant du nouveau-né. La méthode est particulièrement utile pour diagnostiquer les nourrissons prématurés ou les nouveaux-nés à faible poids de naissance.
Patent EP-3562745-A1 (EP)
Inventor: PALUMBO RICCARDO
IPC: B65B11/52
Filed: 2017-12-28
Abstract: The present invention refers to a packaging apparatus (1) wherein a conveyor (3) moves one or more supports (4) towards a packaging station, while a plastic film to be applied to said one or more supports is simultaneously transported to the packaging station itself. A longitudinally cutting unit longitudinally cuts the plastic film in order to form two or more film strips, and a compensating device exerts a tensioning action on one or more portions of said film strips. It is also described a packaging method wherein it is provided to longitudinally cut the plastic film into strips and a compensating step destined to suitably tautly hold the film strips during their movement.
Patent EP-3491383-A1 (EP)
Title: Taux salivaires d'abêta42 en tant qu'indicateurs pronostiques de la maladie d'alzheimer
Inventor: MCGEER PATRICK L
IPC: A61P25/28
Filed: 2017-07-24
Abstract: La présente invention concerne des procédés et des kits pour la détermination précise des taux salivaires d'Abêta42. Un procédé d'analyse d'un échantillon de salive comprend les étapes d'obtention de l'échantillon de salive d'un sujet ; stabilisation de l'échantillon de salive ; mesure du taux d'Abêta42 présent dans l'échantillon de salive stabilisé par mise en contact de l'échantillon de salive stabilisé avec un anticorps capable de se lier à Abêta42 ; comparaison du taux déterminé d'Abêta42 présent dans la salive stabilisée à celui d'un taux témoin d'Abêta42 dérivé d'un échantillon de salive d'un échantillon de groupe témoin non affecté ; et affichage de la comparaison du taux déterminé et du taux témoin, le taux déterminé relatif étant supérieur au taux témoin étant indicatif de la présence de la maladie d'Alzheimer chez le sujet ou du fait que le sujet présente un risque de développer la maladie d'Alzheimer.
Patent EP-3493538-A1 (EP)
Inventor: OKADA TAKASHI
IPC: B42D25/328
Filed: 2017-07-13
Abstract: This color calibration device is a color calibration device, calibrating colors in a captured image of a first imaging device between different imaging devices using a hologram emitting diffracted light at different frequencies corresponding to an observation angle, the color calibration device includes: a diffracted light spectral distribution calculation unit that obtains respective diffracted light spectral distribution of the diffracted light from the hologram; a camera sensitivity function estimation unit that estimates spectral sensitivity of the imaging device from the respective diffracted light spectral distribution of the diffracted light and each captured image of the diffracted light; and a color calibration unit that calibrates difference in color of the first imaging device relative to a second imaging device different from the first imaging device using the estimated spectral sensitivity.
Patent EP-3561510-A1 (EP)
Title: Detection substrate and manufacturing method therefor, and method for detecting nucleic acids
Inventor: PANG FENGCHUN
IPC: C12M1/40
Filed: 2017-07-12
Abstract: A detection substrate and a manufacturing method thereof, and a nucleic acid detecting method are provided. The detection substrate includes at least one detection unit (100) disposed on a base substrate (10), the detection unit (100) including a first electrode (11), a second electrode (13) and a colloid layer (17), the second electrode (13) disposed on a side of the first electrode (11) away from the base substrate (10), the second electrode (13) including at least one hollowed structure (1300), the second electrode (13) and the first electrode (11) being insulated from each other, and the first electrode (11) and the second electrode (13) being configured to be applied with voltages respectively; the colloid layer (17) at least disposed on the at least one hollowed structure (1300) of the second electrode (13), the colloid layer (17) including a linker (170) configured to be paired with a target nucleic acid (18). The detection substrate performs the amplification and detection of the nucleic acid by applying voltages to the first electrode (11) and the second electrode (13) of the detection unit (100) respectively. A requirement on the structure and appearance of the first electrode (11) and the second electrode (13) are simple, which simplifies the process difficulty.
Patent EP-3494661-A1 (EP)
Title: Procédé et appareil de signalisation de signal de référence pour des communications sans fil avancées
Inventor: GUO LI
IPC: H04L5/00
Filed: 2017-08-03
Abstract: La présente invention concerne un système de communication de pré-5 e génération (5G) ou 5G en vue de prendre en charge des débits de données supérieurs à ceux d'un système de communication de 4e génération (4G), tel que LTE (évolution à long terme). La présente invention concerne également un procédé appliqué à un équipement d'utilisateur (UE) pour configurer un signal de référence (RS) de bruit de phase dans un système de communications avancées. Le procédé comprend : la réception, en provenance d'une station de base (BS), d'informations de configuration du signal de référence de bruit de phase à l'aide d'un signal RRC (signal de commande de ressource radio) et d'informations DCI (informations de commande de liaison descendante) par le biais d'un schéma de signalisation hybride incluant des informations du signal de référence de bruit de phase ; l'identification d'un modèle de mappage de signal de référence sur la base des informations de configuration du signal de référence de bruit de phase signalisé dans le signal RRC et les informations DCI par le biais du schéma de signalisation hybride ; la réalisation d'une estimation de canal et d'un suivi de phase pour un canal de liaison descendante dans une largeur de bande (BW) planifiée selon le modèle de mappage de signal de référence identifié ; et la réception, en provenance de la station de base, de données de liaison descendante sur le canal de liaison descendante dans la largeur de bande planifiée.
Patent EP-3559023-A1 (EP)
Inventor: PRETORIUS ALRI
IPC: A61K39/02
Filed: 2017-12-20
Abstract: The present invention relates to nucleic acids comprising sequences encoding  Ehrlichia ruminantium  epitopes which induce a CD4 immune response, and sequences encoding  Ehrlichia ruminantium  epitopes which induce a CD8 immune response. The invention also relates to multi-epitope DNA vaccines comprising the nucleic acids and the polypeptides encoded by the nucleic acids. The invention further relates to uses and methods of eliciting an immune response against heartwater disease in a subject using the nucleic acids, multi-epitope DNA vaccines and polypeptides.
Patent EP-3497664-A1 (EP)
Title: Plate-forme personnalisée de protection d'un hôte dans un partage domestique
Inventor: SNYDER JENNIFER L
IPC: G06Q50/18
Filed: 2017-08-14
Abstract: L'invention concerne un système d'assurance pour un partage domestique qui peut comprendre un dispositif mobile d'un propriétaire, une ou plusieurs bases de données stockant des données de facteur d'assurance, une pluralité de capteurs configurés de manière à surveiller une ou plusieurs caractéristiques de maison, et un serveur comprenant un ou plusieurs processeurs et une mémoire. Le serveur peut être configuré de manière à recevoir, en provenance du dispositif mobile, des données indiquant que le propriétaire loue un domicile, déterminer une valeur pour la fréquence de locations pour la maison sur la base des données indiquant que le propriétaire loue la maison, et recevoir, en provenance de la pluralité de capteurs, des données surveillées pour une ou plusieurs des caractéristiques de la maison. Le serveur peut calculer une prime d'assurance pour le propriétaire sur la base de la valeur pour la fréquence de locations pour la maison, les données surveillées pour une ou plusieurs des caractéristiques de la maison, et les données de facteur d'assurance et transmettre la prime d'assurance au dispositif mobile.
Patent EP-3485860-A1 (EP)
Inventor: MUKAI HIROTOMO
IPC: A61F13/494
Filed: 2017-08-09
Abstract: An absorbent article includes: an absorbent body (11) having a longitudinal direction and a lateral direction orthogonal to each other; and a pair of leak-proof walls (50) provided on both lateral sides of the absorbent body (11). Each of the leak-proof walls is formed of a sheet member (50s) including a plurality of first welded parts (61) on a surface of the sheet member (50s). And, each of the leak-proof walls (50) includes an overlaid part (50L) where the sheet member (50s) is overlaid in a thickness direction such that an elastic member (52) stretching/contracting in the longitudinal direction is sandwiched. In at least a part of a region of the overlaid part (50L), a plurality of second welded parts (62) that join the overlaid sheet member (50s) is disposed. An area of the second welded parts (62) is smaller than an area of the first welded parts (61).
Patent EP-3522160-A1 (EP)
Title: Information reproduction device and information reproduction method
Inventor: NAKAJIMA SHIGEO
IPC: G11B5/09
Filed: 2017-09-22
Abstract: A card reader 10 is provided with a peak detection unit 142 which detects a peak point of a reproduction signal from a digital signal in accordance with a threshold value, i.e. a determination level which is made to track the output of an AD converter 141. The peak detection unit 142 applies a second peak value VP2 which is the previous peak value with respect to a first peak value VP1 to be determined, a third peak value VP3 which is the peak value prior to the second peak value, and the next peak value VP4 with respect to the first peak value VP1 to be determined, and, if the difference between a first intermediate value VCT1 between the third peak value VP3 and the second peak value VP2, and a second intermediate value VCT2 between the second peak value VP2 and the first peak value VP1 is equal to or greater than a first difference value DF1, disregards a first threshold value JVL1, confirms that a digital value corresponding to the next peak value VP4 exceeds a second threshold value JVL2, and establishes the first peak value VP1.
Patent EP-3519352-A1 (EP)
Inventor: KAPPAGANTULA KEERTI S
IPC: H01B1/04
Filed: 2017-09-27
Abstract: A method of forming a metal-graphene composite includes coating metal components (10) with graphene (14) to form graphene-coated metal components, combining a plurality of the graphene-coated metal components to form a precursor workpiece (26), and working the precursor workpiece (26) into a bulk form (30) to form the metal-graphene composite. A metal-graphene composite includes graphene (14) in a metal matrix wherein the graphene (14) is single-atomic layer or multi-layer graphene (14) distributed throughout the metal matrix and primarily (but not exclusively) oriented with a plane horizontal to an axial direction of the metal-graphene composite.
Patent EP-3528843-A1 (EP)
Inventor: JANDA KIM D
IPC: G01N33/94
Filed: 2017-10-17
Abstract: The invention provides haptens and methods of preparation thereof, for producing immunoconjugates of oxycodone and hydrocodone suitable for raising antibodies in animals specific for the opioid drugs. Adminislration of the opioid-speeific antibodies to humans having the opioid drugs in a body fluid such as blood serum, binds the opioid drugs to the antibody, making the opioids unavailable for producing a drug effect. Accordingly the antibodies can be used to reverse the effects of a drug overdose of oxycodone and hydrocodone, or to reverse a perceived mental effect of the. drugs, such as euphoria.
Patent EP-3534924-A1 (EP)
Inventor: BOULET ANDRÉ P
IPC: A61P39/06
Filed: 2017-11-03
Abstract: There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of cardiovascular diseases, and method for the treatment thereof. The cardiovascular diseases (CVD) may comprise several diseases associated with inflammation of the heart or arteries and include coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack), atherosclerosis, stroke, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis.
Patent EP-3543961-A1 (EP)
Inventor: ICHIKAWA HIROTAKE
IPC: G06T19/00
Filed: 2017-08-30
Abstract: [Object] To propose an information processing device, information processing method, and program capable of appropriately deciding objects arranged in a virtual space generated on the basis of sensing of a real space. 
     [Solution] An information processing device including: a decision unit that decides, on the basis of a predetermined reference, a shared object arranged in a virtual space that is generated for communication between a first user and a second user on the basis of a sensing result of a first real space including at least one first actual object in relation to the first user and a sensing result of a second real space including at least one second actual object in relation to the second user.